ChemicalBook > CAS DataBase List > L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[1-[(acetyloxy)methyl]-2-hydroxypropyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]- (9CI)

L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[1-[(acetyloxy)methyl]-2-hydroxypropyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]- (9CI)

L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[1-[(acetyloxy)methyl]-2-hydroxypropyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]- (9CI) Structure
L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[1-[(acetyloxy)methyl]-2-hydroxypropyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]- (9CI)
  • CAS No.133304-81-1
  • Chemical Name:L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[1-[(acetyloxy)methyl]-2-hydroxypropyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]- (9CI)
  • CBNumber:CB78090415
  • Molecular Formula:C51H68N10O11S2
  • Formula Weight:1061.28
  • MOL File:133304-81-1.mol
L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[1-[(acetyloxy)methyl]-2-hydroxypropyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]- (9CI) Property
  • Boiling point 1409.9±65.0 °C(Predicted)
  • Density 1.38±0.1 g/cm3(Predicted)
  • pka 12.59±0.70(Predicted)
Hazard and Precautionary Statements (GHS)
  • Symbol(GHS)
  • Signal word
  • Hazard statements
  • Precautionary statements

L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[1-[(acetyloxy)methyl]-2-hydroxypropyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]- (9CI) Chemical Properties,Usage,Production

  • Uses O-Acetyl Octreotide is a derivative of Octapeptide (O239950), an analog of Somatostatin. A gastric antisecretory agent. Used in treatment of acromegaly.
L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[1-[(acetyloxy)methyl]-2-hydroxypropyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]- (9CI) Preparation Products And Raw materials
Raw materials
Preparation Products
L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[1-[(acetyloxy)methyl]-2-hydroxypropyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]- (9CI) Suppliers
Global(21)Suppliers
  • Supplier:
    Moxin Chemicals
  • Tel: +8617320513646
  • Email:Anna@molcoo.com
  • Country:China
  • ProdList:9684
  • Advantage:58
  • Supplier: ChemStrong Scientific Co.,Ltd
  • Tel:0755-0755-66853366<br/>13670046396
  • Email:sales@chem-strong.com
  • Country:China
  • ProdList:18146
  • Advantage:56
  • Supplier: Molcoo Chemicals Inc.
  • Tel: 18576690171
  • Email:3001025734@qq.com
  • Country:China
  • ProdList:10829
  • Advantage:58
L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[1-[(acetyloxy)methyl]-2-hydroxypropyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]- (9CI) Spectrum
133304-81-1, L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[1-[(acetyloxy)methyl]-2-hydroxypropyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]- (9CI)Related Search:
  • 杂质对照品
  • C51H68N10O11S2
  • 醋酸奥曲肽杂质6 醋酸盐(奥曲肽EP杂质F 醋酸盐)
  • 奥曲肽EP杂质F(三氟乙酸盐)
  • 2-(13-((1H-吲哚-3-基)甲基)-19-(2-氨基-3-苯丙胺)-10-(4-氨基丁基)-16-苄基-7-(1-羟乙基)-6,9,12,15,18-五氧基-1,2-二硫基-5,8,11,14,17-五氮杂环丙烷-4-甲酰胺)-3-羟基乙酸丁酯 (奥曲肽杂质)
  • 醋酸奥曲肽杂质6(奥曲肽EP杂质F)
  • 醋酸奥曲肽杂质F
  • 奥曲肽EP杂质F
  • 133304-81-1
  • Octreotide impurity F (EP/BP)
  • Octreotide Acetate Impurity 6 Acetate(Octreotide EP Impurity F Acetate)
  • 2-(13-((1H-Indol-3-yl)methyl)-19-(2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-7-(1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamido)-3-hydroxybutyl acetate (Octreotide Impurity)
  • (2R,3R)-2-((4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((R)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamido)-3-hydroxybutyl acetate
  • (2R,3R)-2-((4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((R)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamido)-3-hydroxybutyl acetate 2,2,2-trifluoroacetate
  • (2R,3R)-2-((4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((R)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pent
  • O1(Ac)]8-Octreotide (10 mg) (D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(2R,3R)-1-acetoxy-3-hydroxybutan-2-yl]-L-cysteinamide cyclic (2-->7)-disulfide)
  • Octreotide Acetate Impurity 6(Octreotide EP Impurity F)
  • Octreotide acetate impurity F
  • O1.8-acetyloctreotide
  • Octreotide - Impurity FQ: What is Octreotide - Impurity F Q: What is the CAS Number of Octreotide - Impurity F
  • Octreotide Acetate Impurity 6
  • Octreotide EP Impurity F
  • L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[1-[(acetyloxy)methyl]-2-hydroxypropyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]- (9CI)